Wellington Management Group LLP Bei Gene, Ltd. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$179.87 - $225.13 $3.64 Million - $4.56 Million	20,239 Added 57.43%	55,478 $9.98 Million
Q2 2023 Aug 14, 2023	BUY	$178.3 - $266.78 $4.63 Million - $6.92 Million	25,947 Added 279.24%	35,239 $6.28 Million
Q1 2023 May 12, 2023	BUY	$215.53 - $274.5 $2 Million - $2.55 Million	9,292 New	9,292 $2 Million
Q2 2022 Aug 15, 2022	SELL	$121.11 - $216.05 $9.08 Million - $16.2 Million	-75,004 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$146.52 - $269.56 $99 Million - $182 Million	-675,876 Reduced 90.01%	75,004 $14.1 Million
Q4 2021 Feb 11, 2022	SELL	$248.56 - $389.34 $24.8 Million - $38.9 Million	-99,923 Reduced 11.74%	750,880 $203 Million
Q3 2021 Nov 15, 2021	SELL	$249.6 - $403.14 $22.7 Million - $36.7 Million	-91,113 Reduced 9.67%	850,803 $309 Million
Q2 2021 Aug 16, 2021	SELL	$292.75 - $367.01 $74.1 Million - $92.9 Million	-253,068 Reduced 21.18%	941,916 $323 Million
Q1 2021 May 17, 2021	SELL	$260.64 - $382.12 $64.8 Million - $95 Million	-248,554 Reduced 17.22%	1,194,984 $416 Million
Q4 2020 Feb 12, 2021	SELL	$221.31 - $316.61 $48.2 Million - $68.9 Million	-217,711 Reduced 13.11%	1,443,538 $373 Million
Q3 2020 Nov 16, 2020	SELL	$189.18 - $286.44 $56 Million - $84.7 Million	-295,862 Reduced 15.12%	1,661,249 $476 Million
Q2 2020 Aug 14, 2020	SELL	$123.9 - $195.41 $10.6 Million - $16.8 Million	-85,885 Reduced 4.2%	1,957,111 $369 Million
Q1 2020 May 14, 2020	SELL	$121.84 - $173.19 $29.8 Million - $42.4 Million	-244,801 Reduced 10.7%	2,042,996 $252 Million
Q4 2019 Feb 11, 2020	BUY	$115.78 - $208.34 $265 Million - $477 Million	2,287,797 New	2,287,797 $379 Million

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$2.03 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.24 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$995 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$956 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$712 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.9B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account